BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20013195)

  • 1. Application of membrane extraction with sorbent interface for breath analysis.
    Ma V; Lord H; Morley M; Pawliszyn J
    Methods Mol Biol; 2010; 610():451-68. PubMed ID: 20013195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of human breath with micro extraction techniques and continuous monitoring of carbon dioxide concentration.
    Ma W; Liu X; Pawliszyn J
    Anal Bioanal Chem; 2006 Aug; 385(8):1398-408. PubMed ID: 16847622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental setup and analytical methods for the non-invasive determination of volatile organic compounds, formaldehyde and NOx in exhaled human breath.
    Riess U; Tegtbur U; Fauck C; Fuhrmann F; Markewitz D; Salthammer T
    Anal Chim Acta; 2010 Jun; 669(1-2):53-62. PubMed ID: 20510903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human exhaled air analytics: biomarkers of diseases.
    Buszewski B; Kesy M; Ligor T; Amann A
    Biomed Chromatogr; 2007 Jun; 21(6):553-66. PubMed ID: 17431933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
    Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
    Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sorbent-based sampling methods for volatile and semi-volatile organic compounds in air. Part 2. Sorbent selection and other aspects of optimizing air monitoring methods.
    Woolfenden E
    J Chromatogr A; 2010 Apr; 1217(16):2685-94. PubMed ID: 20106482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
    Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
    Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breath acetone analysis with miniaturized sample preparation device: in-needle preconcentration and subsequent determination by gas chromatography-mass spectroscopy.
    Ueta I; Saito Y; Hosoe M; Okamoto M; Ohkita H; Shirai S; Tamura H; Jinno K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(24):2551-6. PubMed ID: 19595647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On-line monitoring of breath by membrane extraction with sorbent interface coupled with CO2 sensor.
    Yu Y; Pawliszyn J
    J Chromatogr A; 2004 Nov; 1056(1-2):35-41. PubMed ID: 15595530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic potential of breath analysis--focus on volatile organic compounds.
    Miekisch W; Schubert JK; Noeldge-Schomburg GF
    Clin Chim Acta; 2004 Sep; 347(1-2):25-39. PubMed ID: 15313139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volatile organic compounds as diagnostic biomarkers in gastrointestinal and liver diseases.
    Probert CS; Ahmed I; Khalid T; Johnson E; Smith S; Ratcliffe N
    J Gastrointestin Liver Dis; 2009 Sep; 18(3):337-43. PubMed ID: 19795029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of breath acetone concentrations by selected ion flow tube mass spectrometry in type 2 diabetes.
    Storer M; Dummer J; Lunt H; Scotter J; McCartin F; Cook J; Swanney M; Kendall D; Logan F; Epton M
    J Breath Res; 2011 Dec; 5(4):046011. PubMed ID: 22134047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GC-MS analysis of breath odor compounds in liver patients.
    Van den Velde S; Nevens F; Van Hee P; van Steenberghe D; Quirynen M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov; 875(2):344-8. PubMed ID: 18938115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
    Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
    Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volatile biomarkers of pulmonary tuberculosis in the breath.
    Phillips M; Cataneo RN; Condos R; Ring Erickson GA; Greenberg J; La Bombardi V; Munawar MI; Tietje O
    Tuberculosis (Edinb); 2007 Jan; 87(1):44-52. PubMed ID: 16635588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A profile of volatile organic compounds in breath discriminates COPD patients from controls.
    Van Berkel JJ; Dallinga JW; Möller GM; Godschalk RW; Moonen EJ; Wouters EF; Van Schooten FJ
    Respir Med; 2010 Apr; 104(4):557-63. PubMed ID: 19906520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can volatile compounds in exhaled breath be used to monitor control in diabetes mellitus?
    Smith D; Spaněl P; Fryer AA; Hanna F; Ferns GA
    J Breath Res; 2011 Jun; 5(2):022001. PubMed ID: 21512208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
    Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
    J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of breath and skin analysis for monitoring blood glucose concentration in diabetes.
    Turner C
    Expert Rev Mol Diagn; 2011 Jun; 11(5):497-503. PubMed ID: 21707458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a protocol to measure volatile organic compounds in human breath: a comparison of rebreathing and on-line single exhalations using proton transfer reaction mass spectrometry.
    O'Hara ME; O'Hehir S; Green S; Mayhew CA
    Physiol Meas; 2008 Mar; 29(3):309-30. PubMed ID: 18367807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.